Human medicines European public assessment report EPAR Slenyto melatonin Sleep Initiation and Maintenance DisordersAutistic Disorder Date of authorisation 20092018 Status Authorised

Human medicines European public assessment report (EPAR): Slenyto, melatonin, Sleep Initiation and Maintenance Disorders,Autistic Disorder, Date of authorisation: 20/09/2018, Status: Authorised

Human medicines European public assessment report (EPAR): Slenyto, melatonin, Sleep Initiation and Maintenance Disorders,Autistic Disorder, Date of authorisation: 20/09/2018, Status: Authorised

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Slenyto, melatonin, Sleep Initiation and Maintenance Disorders,Autistic Disorder, Date of authorisation: 20/09/2018, Status: Authorised"